Impacto de los antivirales de acción directa en las manifestaciones extrahepáticas en la hepatitis C crónica: una revisión narrativa con un enfoque hermenéutico
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Ver abstracta en PubMed
Resumen
Este resumen es generado por máquina.Los antivirales de acción directa (AAD) logran un alto aclaramiento viral en la vasculitis crioglobulinémica mixta (CryoVas) relacionada con el virus de la hepatitis C. Sin embargo, la resolución clínica de los síntomas varía, lo que requiere un monitoreo personalizado de las manifestaciones extrahepáticas.
Área De La Ciencia
- Hepatología
- Inmunología
- Reumatología
Sus Antecedentes
- La infección crónica por el virus de la hepatitis C (VHC) causa diversas manifestaciones extrahepáticas, en particular la vasculitis crioglobulinémica mixta (CryoVas).
- Comprender el impacto sistémico del VHC y la eficacia del tratamiento para las afecciones asociadas es crucial.
Objetivo Del Estudio
- Revisar las condiciones extrahepáticas relacionadas con el VHC.
- Analizar los resultados clínicos y virológicos de la terapia antiviral de acción directa (DAA) en pacientes con CryoVas.
Principales Métodos
- Revisión sistemática de las manifestaciones extrahepáticas del VHC en los ámbitos inmunológico, inflamatorio, dermatológico, tiroideo y neuropsiquiátrico.
- Análisis comparativo de cinco estudios sobre el impacto del tratamiento con DAA en pacientes con CryoVas, resumiendo los datos demográficos, los síntomas y las tasas de respuesta.
Principales Resultados
- El VHC está relacionado con la crioglobulinemia mixta, el linfoma, la tiroiditis, la resistencia a la insulina y los problemas neurocognitivos.
- El tratamiento con DAA mostró una alta respuesta virológica (88,9-100%) en pacientes con CryoVas, pero la remisión clínica varió ampliamente (39-90% respuesta completa).
- Se produjo una mejora significativa de los síntomas, pero algunos pacientes presentaron problemas persistentes después de la SVR, lo que indica la necesidad de una evaluación inmunológica adicional.
Conclusiones
- La infección por el VHC afecta a múltiples sistemas más allá del hígado.
- Los AAD eliminan eficazmente el virus, pero las respuestas clínicas heterogéneas en CryoVas requieren una mayor vigilancia de los resultados extrahepáticos.
- Las investigaciones futuras deben explorar la combinación de AAD con agentes inmunomoduladores para las CryoVas graves o refractarias.
Contact us Si estos videos no son relevantes.
Contact us Si estos videos no son relevantes.
Videos de Conceptos Relacionados
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...